Trident Lifeline Ltd

Trident Lifeline Ltd has announced that its Board of Directors will convene on July 29, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results for both standalone and consolidated operations for the quarter ended June 30, 2026. Additionally, the meeting will address any other business as permitted by the chairman. The company also confirmed the closure and reopening of its trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Trident Lifeline Ltd has announced the closure of its trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be closed effective July 01, 2026, and will reopen 48 hours after the conclusion of the Board of Directors' meeting. This meeting is scheduled to consider the Un-Audited Financial Results for the quarter ended June 30, 2026. The exact date of the board meeting will be communicated separately. This measure is standard practice to prevent potential insider trading ahead of financial result announcements.

Trident Lifeline Ltd announced that its subsidiary, Trident Mediquip Limited (TML), has completed a private placement of equity shares. Following this placement to other shareholders, Trident Lifeline's shareholding in TML has decreased from 58.84% to 58.67%. TML operates in the Medical Device Industry and had a turnover of ₹27.31 Cr in FY26. The transaction is considered a related party transaction as TML is a subsidiary, but it is being conducted on an arm's length basis. No specific financial consideration or acquisition details were provided as the transaction involved existing shareholders.

Hardik Desai Family Trust, classified under the Promoter Group, has acquired 1,200 shares of Trident Lifeline Limited through open market transactions. This acquisition, executed on June 12, 2026, has marginally increased the trust's total shareholding to 8,57,366 shares, representing 7.78% of the total share capital and 6.86% of the diluted share capital. The total equity share capital of the company remains at ₹11,93,30,000.

Trident Lifeline Ltd's Board of Directors convened on June 13, 2026, approving the appointment of Ms. Smita Kiran Davda and Mr. Sachin Bhandari as Non-Executive Independent Directors for a five-year term, subject to shareholder approval. The board also approved the migration of the company's securities from the BSE SME platform to the Main Boards of BSE and NSE. Additionally, plans for a postal ballot to seek shareholder approval for these changes and the appointment of NSDL as the remote e-voting agency were finalized, with June 5, 2026, set as the cut-off date.

Trident Lifeline Ltd announced that its Board of Directors has approved the appointment of Ms. Smita Davda and Mr. Sachin Bhandari as Additional Non-Executive Independent Directors. Both appointments are effective from June 13, 2026, and are for a term of five years, subject to shareholder approval. The board also approved the migration of the company's securities from the BSE SME platform to the Main Boards of BSE and NSE, along with other corporate actions including the appointment of NSDL as the remote e-voting agency.

Trident Lifeline Ltd announced that its subsidiary, Trident Mediquip Limited (TML), has completed a private placement of equity shares. Following this placement, Trident Lifeline's shareholding in TML has decreased from 59.17% to 58.84%. The transaction involved related parties, including directors' relatives, but was conducted on an arm's length basis. TML operates in the Medical Device Industry with a reported turnover of ₹27.31 Cr for FY26.

Shikha Bafna, identified as a relative of KMP and part of the public category, has filed a disclosure under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. The filing details an acquisition/sale of shares, resulting in a holding of 0.22% of the total diluted share capital of Trident Lifeline Ltd. The transaction occurred on June 3, 2026, via an open market purchase. The total equity share capital before the transaction was Rs. 11,93,30,000/-, and after the transaction, it remained the same, but the diluted share capital increased slightly to Rs. 12,49,34,000/-.

Hardik Desai Family Trust disclosed an update regarding their shareholding in Trident Lifeline Ltd, as per Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The trust acquired 9,000 shares via open market, increasing their holding from 844,166 shares (7.07%) to 853,166 shares (7.15%).

Trident Lifeline Ltd has announced its audited standalone and consolidated financial results for the half year and year ended March 31, 2026. The Board of Directors approved the results in a meeting held on May 7, 2026. The company will publish an extract of the financial results in newspapers and on its website. Additionally, DAC & Co. Chartered Accountants were appointed as the Internal Auditor for the Financial Year 2026-2027.